Mineralys Therapeutics (MLYS) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by CEO, with CFO present and shareholders welcomed.

• Notice of meeting mailed to all shareholders of record as of March 25, 2026.

Corporate governance

• Lou Larson of L-Squared Elections appointed as Inspector of Election, oath filed with meeting minutes.

• Quorum established with proxies representing a majority of outstanding shares.

Overview of voting outcomes

• Two proposals presented: election of three Class III directors for three-year terms and ratification of Ernst & Young LLP as independent auditor for 2026.

• Voting conducted via proxy or live during the meeting; polls closed after proposals reviewed.

• Voting results to be disclosed in a Form 8-K within four business days.